A Digestive Cartridge Reduces Parenteral Nutrition Dependence and Increases Bowel Growth in a Piglet Short Bowel Model.

Authors:
Tsikis ST; Fligor SC; Hirsch TI; Mitchell PD; Pan A and 7 more

Journal:
Ann Surg

Publication Year: 2023

DOI:
10.1097/SLA.0000000000005839

PMCID:
PMC10481911

PMID:
36924229

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Ann Surg

Abbreviation: Ann Surg

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: General Surgery

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
An Updated Systematic Review and Meta-analysis of the Impact of Graduated Compression Stockings in …
Turner BRH; Machin M; Salih M and 6 more (2023) - Transparency Score: 4/6
Association Between Payer Type and Risk of Persistent Opioid Use After Surgery.
Srinivasan S; Gunaseelan V; Jankulov A and 5 more (2023) - Transparency Score: 3/6
Association of Elective Surgical Volume With State Executive Order Curtailing Elective Surgery in M…
Eton RE; Yost ML; Thompson MP and 4 more (2023) - Transparency Score: 3/6
Blood Perfusion Assessment by Indocyanine Green Fluorescence Imaging for Minimally Invasive Rectal …
Watanabe J; Takemasa I; Kotake M and 19 more (2023) - Transparency Score: 4/6
Defining the Full Spectrum of Pediatric Firearm Injury and Death in the United States: It is Even W…
Naik-Mathuria BJ; Naik-Mathuria BJ; Cain CM and 3 more (2023) - Transparency Score: 2/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"M.P. and K.M.G. receive research support and advisory compensation from Alcresta Therapeutics, Inc. (Newton, MA). G.L. and E.F. were employees of Alcresta Therapeutics, Inc. at the time of the study. The remaining authors report no conflicts of interest."

Evidence found in paper:

"This project was supported by Alcresta Therapeutics Inc. (Newton, MA), National Institutes of Health 2T32DK007754-22 (S.T.T.), and 5T32HL007734 (S.C.F., T.I.H.), The Boston Children’s Vascular Biology Program, and The Boston Children’s Hospital Surgical Foundation."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025